Incidence of hepatitis B in hemophilia patients
Thoms, J.; Berles, R.; Syrbe, G.
Folia Haematologica 114(4): 523-529
1987
ISSN/ISBN: 0323-4347 PMID: 2446993 Document Number: 296837
Hepatitis represents a serious complication in the transfusion of blood and blood products. In examining patients from the haemophilia centre in Jena HBsAg was identified in no case, HBsAK, however, in 80% of them. The rate of hepatitis infection increased here with the increasing frequency of transfusion. It should be determined by regularly checking HBsAG, HBsAK and transferases within the scope of prophylactic examinations.
Document emailed within 1 workday
Related Documents
Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483Górska, R.; Ruszkowska, I.; Pniejna-Olszyński, W. 1983: Incidence of caries and periodontal diseases in patients with hemophilia Czasopismo Stomatologiczne 36(7): 559-563
Mauser-Bunschoten, E.P.; Damen, M.; Reesink, H.W.; Roosendaal, G.; Chamuleau, R.A.; van den Berg, H.M. 1996: Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C Annals of Internal Medicine 125(4): 297-299
Nielsen, J.O.; Dietrichson, O.; Juhl, E. 1974: Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme Lancet 2(7886): 913-915
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Patorska-Mach, E.; Pieciński, Z.; Siuciak, J. 1972: Incidence of Australia antigen in patients with acute virus hepatitis and chronic hepatic disorders following virus hepatitis in our records Polski Tygodnik Lekarski 27(50): 1975-1977
Vianello, F.; Tison, T.; Tagariello, G.; Zerbinati, P.; Zanon, E.; Scarano, L.; Girolami, A. 1999: Serological markers of autoimmunity in patients with hemophilia A: the role of hepatitis C virus infection, alpha-interferon and factor VIII treatment in skewing the immune system toward autoreactivity Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 10(6): 393-397
Izquierdo-Ramírez, J.; Contreras-Mulato, E.L.; Sotelo-Ham, E.I.; Marín-Palomares, T.; Dueñas-González, M.T.; Benítez-Aranda, H. 1988: Incidence of inhibitors in children with hemophilia A Boletin Medico del Hospital Infantil de Mexico 45(9): 578-582
Moffatt, L. 2000: The hepatitis C epidemic in the hemophilia community Tennessee Medicine: Journal of the Tennessee Medical Association 93(2): 63; 65
Salmerón, J.; Carmona, I.; Torres, C.; Muñoz de Rueda, P.; Gila, A.; Ruiz-Extremera, A. 1999: Retrospective study of the incidence of hepatitis G virus infection in transfused patients Medicina Clinica 112(11): 409-411
Reaman, G.; Stachewitsch, A.; Mishkin, S. 1977: Chronic active hepatitis in a child with hemophilia a Canadian Medical Association Journal 117(7): 731-732
Mimaya, J. 1981: Management of complications in hemophilia, with special reference to hepatitis Nihon Rinsho. Japanese Journal of Clinical Medicine 39(12): 3707-3714
Cooksley, W.G.; Cowen, A.E.; Powell, L.W. 1973: The incidence of oxyphenisatin ingestion in active chronic hepatitis: a prospective controlled study of 29 patients Australian and New Zealand Journal of Medicine 3(2): 124-128
Mendes-Correa, M.C.ás.; Widman, A.; Brussi, M.L.P.; Guastini, C.F.át.; Gianini, R.J.é 2008: Incidence and predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C in Brazil Aids Patient Care and Stds 22(9): 701-707
Abutidze, A.; Bolokadze, N.; Chkhartishvili, N.; Sharvadze, L.; Tsertsvadze, T. 2016: Incidence of Tuberculosis among Hiv/Hcv Co-Infected Patients Receiving Hepatitis C Treatment with Pegylated Interferon and Ribavirin in Georgia Georgian Medical News 252: 10-15
Lu, S.N.; Chue, P.Y.; Chen, I.L.; Wang, J.H.; Huang, J.F.; Peng, C.F.; Shih, C.H.; Chang, W.Y. 1997: Incidence of hepatitis C infection in a hepatitis C endemic township in southern Taiwan Kaohsiung Journal of Medical Sciences 13(10): 605-608
Rocco, A.; Gargano, S.; Provenzano, A.; Nardone, M.; De Sanctis, G.M.; Altavilla, N.; Chircu, L.V.; Grimaldi, F. 2001: Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection Neuro Endocrinology Letters 22(1): 39-44
Manosuthi, W.; Sungkanuparph, S.; Tansuphaswadikul, S.; Chottanapund, S.; Mankatitham, W.; Chimsuntorn, S.; Sittibusaya, C.; Moolasart, V.; Chaovavanich, A. 2008: Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL Journal of the Medical Association of Thailand 91(2): 159-165
Seeff, L.B.; Wright, E.C.; Zimmerman, H.J.; McCollum, R.W. 1975: Va cooperative study of post-transfusion hepatitis, 1969-1974: incidence and characteristics of hepatitis and responsible risk factors American Journal of the Medical Sciences 270(2): 355-362
Ruan, Y.; Jia, Y.; Zhang, X.; Liang, H.; Li, Q.; Yang, Y.; Li, D.; Zhou, Z.; Luo, F.; Shi, W.; Shao, Y. 2009: Incidence of HIV-1, syphilis, hepatitis B, and hepatitis C virus infections and predictors associated with retention in a 12-month follow-up study among men who have sex with men in Beijing, China Journal of Acquired Immune Deficiency Syndromes 52(5): 604-610